Neurol. praxi. 2009;10(1):54-57

Antiphospholipid syndrome, a syndrome which can mimic multiple sclerosis

MUDr. Petra Nytrová
Neurologická klinika 1. LF UK a VFN, Praha

Antiphospholipid syndrome (APS, also called as Hughes syndrome) is a relatively common autoimmune disorder characterized by recurrent

arterial or venous thromboses and/or pregnancy-related complications with a characteristic finding of antiphospholipid antibodies.

To diagnose APS, the following criteria must be met: one clinical criterion (i. e., the presence of thrombosis or repeated abortions or

preeclampsia) and one laboratory criterion, i. e., the demonstration of some of the antiphospholipid antibodies within a minimal time

interval of 12 weeks between individual laboratory tests. Antiphospholipid antibodies interfere with the homeostasis of blood coagulation

and cause hypercoagulation state by a variety of mechanisms. When APS occurs in patients with rheumatic disease, it is referred

to as secondary APS. The term „primary antiphospholipid syndrome“ (PAPS) is used when no other underlying disease is found. Within

APS, CNS can be involved as well. If this involement is characterized by recurrent arterial occlusions with attack–like course, it can mimic

for example multiple scelrosis (MS) and establishment of correct diagnosis can be difficult. The following case report of a woman, who

has been treated with MS for 10 years, is an evidence thereof. During severe brainstem attack, due to signs of multiorgan involvment

a systemic autoimmune disease was considered, with final conclusion of PAPS, which mimicked MS. The recognition of the correct diagnosis

is of major relevance to treatment planning and secondary prevention of further thrombotic complications.

Keywords: primary antiphospholipid syndrome, secondary antiphospholipid syndrome, Sneddon syndrome, multiple sclerosis

Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nytrová P. Antiphospholipid syndrome, a syndrome which can mimic multiple sclerosis. Neurol. praxi. 2009;10(1):54-57.
Download citation

References

  1. Bolayir E, Yilamz A, Akyuz A. Sneddon's syndrome: Clinical and laboratory analysis of 10 case, Acta Medica Okayma 58, 2003; 59-65.
  2. Cervera R, Piette JCH, Font J, et al. Antiphospholipid syndrome:clinical and immunological manifestation and patterns of disease expression in a cohort of 1 000 patients, Arthritis & Rheumatism 46, 2002; 1019-1027. Go to original source... Go to PubMed...
  3. Ferreira S, D'Cruz DP, Hughes GRV. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where we stand? Rheumatology 44, 2005; 434-442. Go to original source... Go to PubMed...
  4. Hughes GRV. Hughes syndrome The Antiphospholipid syndrome - A clinical overview, Clinical Reviews in Allergy & Immunology 32, 2007; 3-11. Go to original source... Go to PubMed...
  5. Ijdo JW, Conti-Kelly AM, Greco TP. Anti-phospholipid antibodies in patients with multiple scelrosis and MS-like illnesses: MS or APS? Lupus 8, 1999; 109-115. Go to original source... Go to PubMed...
  6. Miyakis S, Lockshin MD, Cervera R. International consensus statemention an update of the classification criteria for definite antiphospholipid syndrome (APS), J Thromb Haemost 4, 2006; 295-306. Go to original source... Go to PubMed...
  7. Roussel V, Ji F, Preud'homme JL. Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients, Journal of Autoimmunity 14, 2000; 259-265. Go to original source... Go to PubMed...
  8. Sanna G, Bertolaccini ML, Hughes GRV. Central nervous system involvement in the antiphospholipid (Hughes) syndrome, Rheumatology 42, 2003; 200-213. Go to original source... Go to PubMed...
  9. Tourbah A, Clapin A, Lyon-Caen O. Systemic autoimmune features and multiple sclerosis, Arch Neurol 55, 1998; 317-332. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.